vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $133.7M, roughly 1.1× FIRST COMMONWEALTH FINANCIAL CORP). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 7.8%, a 20.3% gap on every dollar of revenue. On growth, FIRST COMMONWEALTH FINANCIAL CORP posted the faster year-over-year revenue change (13.0% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 5.5%).
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
FCF vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $133.7M | $151.7M |
| Net Profit | $37.5M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 28.1% | 7.8% |
| Revenue YoY | 13.0% | -41.1% |
| Net Profit YoY | 14.8% | -80.8% |
| EPS (diluted) | $0.37 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | $151.7M | ||
| Q3 25 | $136.0M | $267.8M | ||
| Q2 25 | $131.0M | $244.0M | ||
| Q1 25 | $118.0M | $211.8M | ||
| Q4 24 | $120.4M | $257.6M | ||
| Q3 24 | $121.2M | $78.8M | ||
| Q2 24 | $120.2M | $76.1M |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | $11.8M | ||
| Q3 25 | $41.3M | $55.4M | ||
| Q2 25 | $33.4M | $-17.7M | ||
| Q1 25 | $32.7M | $21.2M | ||
| Q4 24 | $35.8M | $61.6M | ||
| Q3 24 | $32.1M | $-8.8M | ||
| Q2 24 | $37.1M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 20.4% | ||
| Q3 25 | 38.1% | 48.7% | ||
| Q2 25 | 32.1% | 13.8% | ||
| Q1 25 | 34.8% | 38.1% | ||
| Q4 24 | 37.1% | 44.4% | ||
| Q3 24 | 33.4% | 12.3% | ||
| Q2 24 | 38.7% | 7.0% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | 7.8% | ||
| Q3 25 | 30.4% | 20.7% | ||
| Q2 25 | 25.5% | -7.3% | ||
| Q1 25 | 27.7% | 10.0% | ||
| Q4 24 | 29.8% | 23.9% | ||
| Q3 24 | 26.5% | -11.2% | ||
| Q2 24 | 30.9% | -0.5% |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | $2.34 | ||
| Q3 25 | $0.39 | $7.76 | ||
| Q2 25 | $0.32 | $-2.95 | ||
| Q1 25 | $0.32 | $3.33 | ||
| Q4 24 | $0.35 | $11.56 | ||
| Q3 24 | $0.31 | $-1.72 | ||
| Q2 24 | $0.36 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $185.6M |
| Total DebtLower is stronger | $154.9M | — |
| Stockholders' EquityBook value | $1.6B | $329.4M |
| Total Assets | $12.3B | $918.5M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | — | $96.7M | ||
| Q1 25 | — | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | — | $40.8M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | — | ||
| Q3 25 | $262.1M | — | ||
| Q2 25 | $262.4M | — | ||
| Q1 25 | $262.7M | — | ||
| Q4 24 | $263.0M | — | ||
| Q3 24 | $136.3M | — | ||
| Q2 24 | $136.6M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $329.4M | ||
| Q3 25 | $1.5B | $317.2M | ||
| Q2 25 | $1.5B | $235.3M | ||
| Q1 25 | $1.4B | $176.9M | ||
| Q4 24 | $1.4B | $132.4M | ||
| Q3 24 | $1.4B | $60.4M | ||
| Q2 24 | $1.4B | $62.7M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | $918.5M | ||
| Q3 25 | $12.3B | $964.5M | ||
| Q2 25 | $12.2B | $841.0M | ||
| Q1 25 | $11.8B | $761.9M | ||
| Q4 24 | $11.6B | $655.3M | ||
| Q3 24 | $12.0B | $438.5M | ||
| Q2 24 | $11.6B | $422.4M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | $70.4M | ||
| Q3 25 | $49.5M | $99.5M | ||
| Q2 25 | $30.4M | $27.3M | ||
| Q1 25 | $55.9M | $51.0M | ||
| Q4 24 | $129.5M | $54.0K | ||
| Q3 24 | $53.6M | $6.8M | ||
| Q2 24 | $22.7M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | $113.9M | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | 94.6% | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | 12.9% | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | 5.95× | ||
| Q3 25 | 1.20× | 1.80× | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 1.71× | 2.40× | ||
| Q4 24 | 3.61× | 0.00× | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCF
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
